The Academy of Pharmaceutical Sciences announce further workshops for their enormously popular Developability Workshop which ran in 2017
There will be a choice of Northern and Southern venues in 2018
Alderley Park Conference Centre, Macclesfield, Cheshire - 30 & 31 January 2018
The Portway Building, Granta Park, Great Abington, Cambridge - 10 & 11 April 2018
For more information and to book a place on either workshop, go here for Alderley Park, or here for Granta Park.
You will learn from a pharmaceutics and biopharmaceutics perspective what is required to assess a molecule in discovery and its suitability for ‘candidate selection’; determine how ‘developable’ it is with associated risk, time and cost implications and what is needed to progress it through pre-clinical studies and into Phase 1 and 2a clinical studies to achieve Proof of Concept. The workshop will focus on the formulation and analytical aspects of early stage product development for small molecules for oral delivery in particular and put these activities into context with the other disciplines required to progress an asset.
The workshop will be interactive with real life examples, lectures and the ability of attendees to raise issues with compounds they are working on.
Who should attend this workshop?
This workshop is suitable for individuals who:
- Are involved with start-up pharma and biotech companies who need to know what is required to progress their asset through to Proof-of-Concept
- Work for pharma companies and wish to gain a broader understanding of the multi-disciplinary interplay in early drug development
- Work in early development and want to understand how to design and implement science-driven, time-efficient programmes
- Work for CROs or CDMOs and want to broaden their experience
- Are academics or new graduates entering the Pharma industry and want to relate theory to practice
- Are involved with the drug development process and wish to increase their knowledge of the pharmaceutical development (CMC) aspects
The workshop at Alderley Park will be run by John Wahlich, David Elder, Dave Rudd (all ex GSK), Eddie French (ex Pfizer), Peter Scholes (Quotient), David Jones (MHRA) and Paul Dickinson (Seda Pharmaceutical Development Services and ex Astra Zeneca). Granta Park details to follow.
There will be plenty of time for discussions with the course presenters and attendees will be supplied with a detailed set of notes from the workshop. The cost will be £650 + VAT (Alderley Park) and £725 + VAT (Granta Park) including teas / coffees and lunch on both days. Discounts are available for APS members, Students, and Academics.
Website link https://www.apsgb.co.uk/Events/20180130/Default.asp